Received Mar 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z008428 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z013023 | — |
no additional AE; the patient was inadvertently administered VARIVAX during a temperature excursion; This spontaneous report was received from other health professional and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 04-Feb-2026, the patient was inadvertently administered with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) lyophilisate and solvent for solution for injection (0.50 ml) (dose text: 0.5 ml/ series) (batch/lot number: Z008428) (expiration date: 06-May-2027) or (batch/lot number: Z013023) (expiration date: 12-Aug-2027) together with sterile diluent unknown batch/lot number, during a temperature excursion (exact administered lot of VARIVAX was unknown as there were two involved in the overall excursion); temperature: -11.75C, time frame: 48 minutes (product storage error). No additional AE (no adverse event).
sterile diluent